GFAP and depressive disorder: As shown in Figure 4A-B, compared with WT mice, the number of GFAP-positive cells in the hippocampus of CKO mice was significantly reduced after CSDS (p = 0.0021), indicating that astrocytic Kir6.1 deficiency promotes the loss of astrocytes in depression.